Company news
Vitrafy Life Sciences Ltd. (ASX:VFY) news
Vitrafy Life Sciences Ltd. news releases on 6ix. Latest, Sep 30, 2026: Vitrafy enters partnership with Versiti Blood Health
Press releases & updates
Vitrafy enters partnership with Versiti Blood Health
September 29, 2026
S&P DJI Announces September 2026 Quarterly Rebalance
September 4, 2026
Vitrafy enters U.S. Cell & Gene Therapy Market
September 1, 2026
FY26 Full Year Results Presentation
August 3, 2026
Q4 FY26 Quarterly Activities Report and Appendix 4C
July 28, 2026
Vitrafy enters a partnership with Hoxworth Blood Center
July 22, 2026
Vitrafy Share Purchase Plan Opens - SPP Offer Booklet
June 18, 2026
Vitrafy Equity Raising Presentation
June 11, 2026
Trading Halt
June 9, 2026
Vitrafy enters a partnership with Vitalant Innovation Center
June 1, 2026
Phase 2 USAISR Platelet Results Investor Presentation
May 21, 2026
Q3 FY26 Quarterly Activities Report and Appendix 4C
April 27, 2026
USAISR Completes Phase 2 Platelet Study
April 7, 2026
FY26 Half Year Results Presentation
February 3, 2026
FY26 Appendix 4D and Half Year Report
February 3, 2026
Q2 FY26 Quarterly Activities Report and Appendix 4C
January 28, 2026
Vitrafy Enters Strategic Commercial Agreement with IMV
January 14, 2026
IMV Strategic Partnership Investor Presentation
January 14, 2026
Q1 FY26 Quarterly Activities Report and Appendix 4C
October 21, 2025
FY25 Full Year Results Presentation - Amended
August 5, 2025
FY25 Appendix 4E and Annual Report
August 4, 2025
FY25 Full Year Results Presentation
August 4, 2025
Leadership Transition at Vitrafy
August 4, 2025
Q4 FY25 Quarterly Activities Report and Appendix 4C
July 29, 2025
Q3 FY25 Quarterly Activities Report and Appendix 4C
April 28, 2025
USAISR successful Phase 1 Blood Platelet study
April 15, 2025
Vitrafy Awarded Industry Growth Program Grant
March 18, 2025
FY25 Appendix 4D and Half Year Report
February 5, 2025
FY25 Half Year Results Presentation
February 5, 2025
Q2 FY25 Quarterly Activities Report and Appendix 4C
January 30, 2025